Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.

Knabel MK, Ramachandran K, Karhadkar S, Hwang HW, Creamer TJ, Chivukula RR, Sheikh F, Clark KR, Torbenson M, Montgomery RA, Cameron AM, Mendell JT, Warren DS.

PLoS One. 2015 Apr 29;10(4):e0124411. doi: 10.1371/journal.pone.0124411. eCollection 2015.

2.

Successful transplantation of kidney allografts in sensitized rats after syngeneic hematopoietic stem cell transplantation and fludarabine.

Fu Y, Sun Z, Fuchs EJ, Wang Y, Shen ZY, Maeda H, Lin Q, Warren DS, Williams GM, Montgomery RA.

Am J Transplant. 2014 Oct;14(10):2375-83. doi: 10.1111/ajt.12815. Epub 2014 Aug 19.

PMID:
25139564
3.

HLA incompatible renal transplantation.

Montgomery RA, Warren DS, Segev DL, Zachary AA.

Curr Opin Organ Transplant. 2012 Aug;17(4):386-92. doi: 10.1097/MOT.0b013e328356132b. Review.

PMID:
22790073
4.

In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expression.

Lonze BE, Holzer HT, Knabel MK, Locke JE, DiCamillo GA, Karhadkar SS, Montgomery RA, Sun Z, Warren DS, Cameron AM.

Arch Surg. 2012 Apr;147(4):384-7. doi: 10.1001/archsurg.2011.1250.

PMID:
22508787
5.

Outcomes of ABO-incompatible kidney transplantation in the United States.

Montgomery JR, Berger JC, Warren DS, James NT, Montgomery RA, Segev DL.

Transplantation. 2012 Mar 27;93(6):603-9. doi: 10.1097/TP.0b013e318245b2af.

6.

Humoral immunity and antibody-mediated rejection in solid organ transplantation.

Montgomery RA, Cozzi E, West LJ, Warren DS.

Semin Immunol. 2011 Aug;23(4):224-34. doi: 10.1016/j.smim.2011.08.021. Epub 2011 Sep 29. Review.

PMID:
21958960
7.

Desensitization in HLA-incompatible kidney recipients and survival.

Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL.

N Engl J Med. 2011 Jul 28;365(4):318-26. doi: 10.1056/NEJMoa1012376.

8.

Incompatible live-donor kidney transplantation in the United States: results of a national survey.

Garonzik Wang JM, Montgomery RA, Kucirka LM, Berger JC, Warren DS, Segev DL.

Clin J Am Soc Nephrol. 2011 Aug;6(8):2041-6. doi: 10.2215/CJN.02940311. Epub 2011 Jul 22.

9.

Perturbation of thymocyte development in nonsense-mediated decay (NMD)-deficient mice.

Frischmeyer-Guerrerio PA, Montgomery RA, Warren DS, Cooke SK, Lutz J, Sonnenday CJ, Guerrerio AL, Dietz HC.

Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10638-43. doi: 10.1073/pnas.1019352108. Epub 2011 Jun 13.

10.

Stem cell mobilization is life saving in an animal model of acute liver failure.

Mark AL, Sun Z, Warren DS, Lonze BE, Knabel MK, Melville Williams GM, Locke JE, Montgomery RA, Cameron AM.

Ann Surg. 2010 Oct;252(4):591-6. doi: 10.1097/SLA.0b013e3181f4e479.

PMID:
20881764
11.

Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange.

Warren DS, Montgomery RA.

Immunol Res. 2010 Jul;47(1-3):257-64. doi: 10.1007/s12026-009-8157-y. Review.

PMID:
20087679
12.

Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody.

Locke JE, Zachary AA, Warren DS, Segev DL, Houp JA, Montgomery RA, Leffell MS.

Am J Transplant. 2009 Sep;9(9):2136-9. doi: 10.1111/j.1600-6143.2009.02764.x. Epub 2009 Jul 30.

13.

Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations.

Kraus ES, Parekh RS, Oberai P, Lepley D, Segev DL, Bagnasco S, Collins V, Leffell M, Lucas D, Rabb H, Racusen LC, Singer AL, Stewart ZA, Warren DS, Zachary AA, Haas M, Montgomery RA.

Am J Transplant. 2009 Aug;9(8):1826-34. doi: 10.1111/j.1600-6143.2009.02701.x. Epub 2009 Jun 16.

14.

ABO incompatible renal transplantation: a paradigm ready for broad implementation.

Montgomery RA, Locke JE, King KE, Segev DL, Warren DS, Kraus ES, Cooper M, Simpkins CE, Singer AL, Stewart ZA, Melancon JK, Ratner L, Zachary AA, Haas M.

Transplantation. 2009 Apr 27;87(8):1246-55. doi: 10.1097/TP.0b013e31819f2024.

PMID:
19384174
15.

Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants.

Stewart ZA, Lonze BE, Warren DS, Dagher NN, Singer AL, Montgomery RA, Segev DL.

Am J Transplant. 2009 May;9(5):1048-54. doi: 10.1111/j.1600-6143.2008.02545.x. Epub 2009 Mar 3.

16.

Kidney transplantation in previous heart or lung recipients.

Lonze BE, Warren DS, Stewart ZA, Dagher NN, Singer AL, Shah AS, Montgomery RA, Segev DL.

Am J Transplant. 2009 Mar;9(3):578-85. doi: 10.1111/j.1600-6143.2008.02540.x.

17.

Renal transplant in HIV-positive patients: long-term outcomes and risk factors for graft loss.

Locke JE, Montgomery RA, Warren DS, Subramanian A, Segev DL.

Arch Surg. 2009 Jan;144(1):83-6. doi: 10.1001/archsurg.2008.508.

PMID:
19153330
18.

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection.

Locke JE, Magro CM, Singer AL, Segev DL, Haas M, Hillel AT, King KE, Kraus E, Lees LM, Melancon JK, Stewart ZA, Warren DS, Zachary AA, Montgomery RA.

Am J Transplant. 2009 Jan;9(1):231-5. doi: 10.1111/j.1600-6143.2008.02451.x. Epub 2008 Oct 31.

19.

Generation of humanized animal livers using embryoid body-derived stem cell transplant.

Locke JE, Sun Z, Warren DS, Sheets TP, Holzer H, Shamblott MJ, Montgomery RA, Cameron AM.

Ann Surg. 2008 Sep;248(3):487-93. doi: 10.1097/SLA.0b013e318185e821.

PMID:
18791369
20.

C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.

Haas M, Segev DL, Racusen LC, Bagnasco SM, Locke JE, Warren DS, Simpkins CE, Lepley D, King KE, Kraus ES, Montgomery RA.

J Am Soc Nephrol. 2009 Jan;20(1):197-204. doi: 10.1681/ASN.2008030279. Epub 2008 Sep 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk